- | Country : -
- | organs : -
- | Specialty : -
Extract
This is a Phase I, double-blind, placebo-controlled, randomised within each dose group, single ascending dose study, with the objective to assess the safety, tolerability and pharmacokinetic profile of AZD8529 in healthy Japanese subjects.
Inclusion criteria
- Healthy